Airrosti's REACH: A Revolutionary Digital Platform for Musculoskeletal Care

Airrosti Unveils REACH: A New Era in Musculoskeletal Care

Airrosti, a prominent name in outcome-focused musculoskeletal (MSK) care, has rolled out a transformative initiative named REACH. This innovative digital platform marks a significant stride in enhancing accessibility to clinically validated musculoskeletal solutions across the nation. By integrating various treatment modalities ranging from initial triage to both virtual and in-person interventions, REACH aims to address the staggering annual costs exceeding $350 billion associated with MSK conditions.

For over 20 years, Airrosti has garnered a reputation for its unique approach to musculoskeletal treatment, emphasizing hands-on myofascial release paired with tailored rehabilitation strategies. This method has yielded superior results for nearly two million patients, proving its effectiveness as a reliable solution for pain management and functional recovery.

Chris Cato, D.C., Airrosti’s Founding Clinician and Chief Population Health Officer, said, "This is a clinical reinvention, not merely a digital extension. For the first time, we’ve successfully adapted our evidence-based myofascial release strategies into a scalable digital format, preserving the stringent clinical standards that are paramount to our success. Through REACH, we can now deliver our effective care model to new markets, identifying and addressing issues earlier in the treatment process."

Unlike conventional digital MSK programs that mainly focus on exercise content and user engagement, REACH emphasizes clinical decision-making and accurate diagnosis. The platform’s architecture facilitates immediate assessment through virtual evaluations, guiding users through the application of Airrosti’s effective treatment principles, and streamlining access to necessary in-person care.

Features of REACH by Airrosti

REACH provides several groundbreaking features tailored to enhance the patient experience:
1. REACH A Doc: This feature ensures that patients can connect with an Airrosti provider for immediate triage, assessment, and direction on their care journey.
2. REACH Rapid Relief: This service offers valuable in-person consultations or virtual sessions based on Airrosti's myofascial release methodology, ensuring that patients receive high-quality care tailored to their needs.
3. REACH Better Movement: A preventive initiative that translates the clinical insights collected over years of practice into a digital framework for self-management and injury prevention.

The digital integration of MSK care has expanded rapidly over the last decade, yet many solutions have plateaued in their effectiveness. Despite the increase in awareness and accessibility, the majority of app-based interventions lacked the capability to diagnose injuries accurately or manage complex cases effectively. Consequently, this led to increased costs for employers without delivering substantial outcomes.

By connecting digital health access with a robust clinical treatment model, REACH aims to close this gap. A recent claims-based study conducted on December 10, 2025, demonstrates the long-term advantages of Airrosti’s approach, revealing a savings of $2,329 per member annually in MSK expenses, and a total medical cost reduction of $3,607 per member.

Mark Metcalfe, CEO of Airrosti, highlighted the broad implications of these outcomes, stating, "We have always believed that expediting patient recovery can yield additional benefits for employers, such as decreased absenteeism and lower medical expenditures. This study underscores our findings that both MSK costs and overall medical expenses are significantly reduced for those treated by Airrosti, reinforcing our commitment to enhancing health outcomes while being cost-effective."

About Airrosti

Airrosti Rehab Centers LLC is a national healthcare organization specializing in outcome-driven musculoskeletal care through integrated solutions encompassing in-person, virtual, and digital formats. Over two decades, Airrosti has gained extensive clinical experience, successfully treating nearly two million patients while achieving consistent improvements in care efficiency and reducing unnecessary interventions.

For those interested in enhancing their understanding of innovative musculoskeletal treatments, further details are available at Airrosti's website.